Report: Small European biotechs suffer from lack of funds

04/14/2005 | Wall Street Journal, The

A report from Critical I found the European biotech industry is being held back by a financial structure unable to help firms move treatments into late-stage research. Because smaller biotechs are unable to secure sufficient funding, many companies close after three to four years. An official with EuropaBio says, "it is crucial the European Union reconsiders how it should stimulate the market to invest in innovation."

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations